Connect with us
European Gaming Congress 2024

Fintech PR

Office of family of Yerzhan Tatishev fight for justice: Convicted assassin could be released early in Kazakhstan

Published

on

office-of-family-of-yerzhan-tatishev-fight-for-justice:-convicted-assassin-could-be-released-early-in-kazakhstan

ASTANA, Kazakhstan, Sept. 11, 2024 /PRNewswire/ — Konayev City Court, in southeast Kazakhstan, will decide on Thursday 12 September whether to release convicted assassin Muratkhan Tokmadi from prison just six years into his 10.5-year sentence for the murder of prominent Kazakh businessman Yerzhan Tatishev, former Chairman and CEO of Bank Turan Alem (‘BTA’).

Tokmadi was not released on 10 August as was previously speculated, following protests to the court for justice. A host of voices, including Tatishev’s family, former colleagues and former United States FBI Director Louis J. Freeh who has investigated the case, say that it is scandalously early to allow Tokmadi to walk free.

Tokmadi killed Yerzhan Tatishev in 2004, but it took 14 years to prove that Tatishev was deliberately murdered, with the court finally convicting Tokmadi in 2018. By claiming that the fatal shotgun blast he fired during a hunting trip had been accidental, Tokmadi initially received a short sentence for manslaughter, avoiding prison. However, further investigation showed that Tokmadi had in fact deliberately murdered Tatishev, supposedly acting on the orders of now-disgraced businessman and former politician, Mukhtar Ablyazov.

Tokmadi gave a television interview in 2017 in which he admitted his complicity in the crime, and his role in subverting justice through paying bribes to make the shooting appear an accident.

Following Tatishev’s death, Ablyazov took over the control of BTA, at the time the largest private bank in Kazakhstan. Under Ablyazov’s control, BTA was defrauded of over $6 billion and entered bankruptcy restructuring. Ablyazov then fled Kazakhstan and continues to face charges.

Louis J. Freeh, Former Director of the FBI, and an investigator acting on behalf of the Tatishev family, stated:

“Muratkhan Tokmadi is a convicted killer and assassin, serving a partial sentence of only six years in prison is contrary to the moral values of Kazakhstan and contrary to natural justice and the rule of law. Early release of criminals from prison is designed to help with their rehabilitation into society, preventing recidivism and so protecting the communities into which they are released.

“Tokmadi now admits no guilt, expresses no remorse, and has no respect for the law. This is not an inmate who should be released from prison early. Instead, because of the extremely serious nature of his crime, Tokmadi should serve his full 10.5-year sentence. He should also be required to testify against Ablyazov and the other conspirators who planned this heinous murder and BTA takeover.”

View original content:https://www.prnewswire.co.uk/news-releases/office-of-family-of-yerzhan-tatishev-fight-for-justice-convicted-assassin-could-be-released-early-in-kazakhstan-302245076.html

Advertisement
Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

SNP Expands in Middle East: New Office in Dubai

Published

on

snp-expands-in-middle-east:-new-office-in-dubai
  • Digital transformation expert now covers all key markets in the region
  • Successful customer projects in the manufacturing, retail, energy and utility industry
  • New subsidiary led by Ravi Mahalingam, Managing Director Middle East

HEIDELBERG, Germany and DUBAI, UAE, Sept. 18, 2024 /PRNewswire/ — SNP SE, a leading provider of software for digital transformation, automated data migration, and data management in SAP environments, has announced the opening of a new office in Dubai’s Internet City. This expansion strengthens SNP’s presence in the region, where it has successfully served major clients such as Tamimi Markets, Gulf Marketing Group, and Qatar Chemicals (QCHEM) over the past two years.

The new office will enable SNP to better serve the Gulf Cooperation Council (GCC) markets, recognized as strategically important for transformation initiatives. Located alongside industry giants like Microsoft, Oracle, and SAP, the office will house a dedicated team focused on enhancing customer relations and expanding the partner network in the Middle East.

The Middle East is one of the fastest-growing markets globally, with significant potential for SAP environment transformations. Analysts predict that the enterprise resource planning (ERP) software market in the Middle East & Africa will grow at an annual rate of 8.3% (CAGR) until 2030. This growth is driven by the increasing complexity of business processes, necessitating greater automation and optimization.

“The Middle East is a crucial market for us, where we have been active and are continuously developing,” says Dr. Jens Amail, CEO of SNP. “We are pleased to now have an office and a competent team familiar with the region’s specific challenges, and we are already seeing initial successes.”

SNP has gained considerable experience in the region, including a successful carve-out for Gulf Marketing Group in the UAE and a near-zero downtime S/4HANA migration for a major Saudi supermarket chain, TAMIMI. Additionally, SNP facilitated an SAP merger and S/4HANA transformation for a leading oil and gas conglomerate.

Pete Sharpe, President of Northern Europe, Middle East & Africa (NEMEA) at SNP, states, “SNP already has a strong footprint with renowned customers and a close partner network in the region. It is crucial to now be on the ground with our own office. We look forward to supporting many more companies in the Middle East with their SAP S/4HANA migrations, carve-outs, and business transformations, considering their specific local needs. The Middle East is one of the fastest-growing markets globally, with clients focusing on digital transformation to drive growth. SNP is well-positioned to support clients in their SAP transformation journey.”

Ravi Mahalingam, who has over 20 years of experience in the region, will head the new office. SNP ME is growing by hiring local talent, building a core team, and investing in the region to support its ambitious growth plans.

About SNP

SNP (ticker: SHF.DE) is the global technology platform leader and trusted partner for companies seeking unparalleled data-enabled transformation capabilities and business agility. SNP’s Kyano platform integrates all necessary capabilities and partner offerings to provide a comprehensive software-based experience in data migration and management. Combined with the BLUEFIELD approach, Kyano sets a comprehensive industry standard for restructuring and modernizing SAP-centric IT landscapes faster and more securely while harnessing data-driven innovations.

The company works with more than 3,000 customers of all sizes and in all industries worldwide, including 20 of the DAX 40 and 103 of the Fortune 500. The SNP Group has more than 1,500 employees worldwide at over 35 locations in 15 countries. The company is headquartered in Heidelberg, Germany, and generated revenues of EUR 203.4 million in the 2023 fiscal year.

More information is available at www.snpgroup.com  

Advertisement

SNP NEMEA Contact

Michelle Janz
Head of Marketing NEMEA
Email: [email protected] 

Press Contact at SNP

Paola Krauss
Mobile: +491727295928
Email: [email protected] 

 

View original content:https://www.prnewswire.co.uk/news-releases/snp-expands-in-middle-east-new-office-in-dubai-302251598.html

Continue Reading

Fintech PR

Transaction Systems and Orion Innovation Announce Strategic Partnership

Published

on

transaction-systems-and-orion-innovation-announce-strategic-partnership

EDISON, N.J., Sept. 18, 2024 /PRNewswire/ — Transaction Systems and Orion Innovation (“Orion”), two prominent leaders in the IT sector, are pleased to announce a strategic partnership to deliver a comprehensive offering of professional services and multiple solutions including Temenos Core Banking Solutions to financial services organizations. This collaboration will see both companies cooperate across presales, sales, and delivery activities to provide top-class solutions, implementation, integration, as well as professional support and maintenance to clients, in the financial services industry.

With this agreement, Transaction Systems and Orion will leverage their combined strengths, capabilities, and strategic solution, to support the financial services market across Europe. Their joint forces will focus on executing professional transformation programs and implementing or replacing critical backend systems, to enhance their clients’ banking operations and services.

For Orion, this partnership enables direct access to the markets and geographies where Transaction Systems operates, expanding its reach and influence. Leveraging Orion’s domain expertise, Transaction Systems will significantly enhance its existing solutions portfolio by incorporating a state-of-the-art core banking solution program, based on Temenos, a leading provider of banking software. Orion subject matter experts from Europe and Asia will complement Transaction System´s professional services competencies.

This partnership establishes a common approach to core banking modernization across multiple markets, including Western Europe, Central and Eastern Europe (CEE), and the Caucasus region.

“We are excited to embark on this partnership with Orion Innovation. By combining our strengths, we are well-positioned to provide unparalleled services to our clients in the banking industry,” said Martin Loeffler, Global CEO at Transaction Systems.

“This collaboration represents a significant opportunity for both companies to strengthen their market position and deliver comprehensive and innovative solutions in core banking for the financial services industry,” added Suchen Janjale, Head of Financial Services, Europe, at Orion Innovation.

About Transaction Systems

TRANSACTION SYSTEMS is a leading provider of innovative technology solutions for the financial and retail services industries, specializing in payment & transaction-related technologies, digital transformation solutions as well as systems integration. Established in 2002, the company currently operates in more than 35 countries worldwide. With a strong geographical presence, TRSYS can support clients around the world, either through its own local teams or via an established network of carefully selected partners. Visit us at https://tr-sys.eu/.

About Orion Innovation

Orion Innovation (“Orion”) is a leading digital transformation and product development services firm. Rooted in engineering and design thinking, along with a unique combination of agility, scale, and maturity, its team of approximately 6,400 associates helps Fortune 1000 companies improve efficiencies, enhance customer experiences, and develop new digital offerings. Through its delivery centers in North America, EMEA, India and Latin America, Orion serves clients across Telecom, Media & Technology, Sports & Entertainment, Professional Services, Financial Services, and Healthcare industries. For more information, visit www.orioninc.com.

Advertisement

Logo – https://mma.prnewswire.com/media/2195243/4240974/Orion_Innovation_Logo.jpg

Continue Reading

Fintech PR

TVM Capital Healthcare Announces Investment in Human Longevity, Inc. as Part of its Strategy of Supporting Disease Prevention and Healthy Aging

Published

on

tvm-capital-healthcare-announces-investment-in-human-longevity,-inc.-as-part-of-its-strategy-of-supporting-disease-prevention-and-healthy-aging

HLI is one of the most established, global longevity science companies and committed to accelerating living to 100+ years of a healthy, active, and mobile life

DUBAI, UAE and RIYADH, Saudi Arabia, Sept. 18, 2024 /PRNewswire/ — TVM Capital Healthcare, an international healthcare expansion and growth capital firm, today announced a recent equity investment in San Francisco-based Human Longevity, Inc. (HLI), a global leader since 2013 in advancing precision medicine in the pursuit of healthy aging, often referred to as longevity medicine. The investment will support the company’s growth within the U.S. market, as well as its expansion into the Kingdom of Saudi Arabia and Southeast Asia.

Founded by Dr. J. Craig Venter, one of the pioneers of the human genome sequencing effort, HLI builds on his vision for a longer, healthier life and the democratization of genomics to revolutionize the way we evade “avoidable disease” and stay healthy longer. The company is recognized as a leader in the rapidly expanding industry of longevity medicine due to its deep expertise in genomics and other fields of precision medicine such as imaging, and its unmatched, longitudinal patient dataset built on decades of research in the field. The company has proprietary tools for the detection of gene-disease associations, including HLI’s artificial intelligence health risk and recommendation platform, and provides its clients with pre-symptomatic diagnosis and customized treatments, preempting disease at a very early stage and maximizing health outcomes. In short, HLI is transforming healthcare from a reactive practice to one that is predictive, proactive, and preventative, which not only enhances the quality of lives of individuals but improves the efficiency and efficacy of the entire healthcare system.

TVM Capital Healthcare brings extensive global investment experience combined with operating experience in the Middle East and Southeast Asia and a track record of building innovative healthcare companies. Through this investment provided by the Saudi Arabia-focused TVM Healthcare Afiyah Fund LP, which closed earlier this year and is the largest growth capital fund of its kind in the region, the firm will support HLI in its expansion, initially with a special focus on market entry in the Kingdom. The country’s Vision 2030 and Health Sector Transformation Program call for an evolution of “sick care” to true “health care,” focusing on the most critical fields of oncology, neurology, metabolic syndrome, and diabetes, as well as cardiovascular and autoimmune disease. Saudi Arabia is highly receptive to healthcare business models such as HLI and has been increasingly active in longevity science with several government-backed initiatives, including the Saudi Human Genome Program and the Hevolution Foundation, a Riyadh-headquartered global non-profit organisation, investing in scientific projects and life science companies in the longevity field.

Dr. J. Craig Venter, Co-Founder and Chief Scientific Advisor of Human Longevity, Inc., commented: “Human Longevity, Inc. is a health firm where the goal is to stay ahead of aging and illness. We believe this platform will save millions of lives and significantly reduce healthcare costs in the future. TVM Capital Healthcare’s investment enables us to strengthen our position globally as the most data-backed longevity practice, as well as establishes our foothold in markets, like Saudi Arabia and SEA, that see the potential of our approach in preventive medicine and the huge impact it will have on changing the cost of medicine.”

Dr. Helmut M. Schuehsler, Chairman and CEO of TVM Capital Healthcare, remarked: “With our investment in HLI, we contribute to the transition towards the ‘healthcare of the future’ which is all about precision medicine, personalized care, and disease prevention, in short: true ‘health care.’  The potential long-term impact of longevity medicine in society is immense. We are excited to be part of the journey through this new investment which supports the growth of the company in the U.S., but also introduces HLI into the Kingdom of Saudi Arabia and Southeast Asia.”

Dr. Ghida Harfouche, Partner at TVM Capital Healthcare, added: “HLI’s cutting-edge science has enabled precision medicine for disease prevention and highly personalized interventions for their clients. We are pleased we can support the company in its global growth, and work with them on democratization of healthy longevity and preventative care.”

TVM Capital Healthcare is recognized as the first international Healthcare fund manager investing in and operating healthcare companies in the Kingdom of Saudi Arabia. The firm is also active across the wider Middle East and Southeast Asia. In addition to backing healthcare growth companies in the U.S. and Europe to support their expansion plans into these regions, TVM Capital Healthcare also invests in leading local companies. With this two-pronged, highly catalytic strategy, TVM Capital Healthcare improves quality and affordable access to world-leading products, technologies, and services across its target markets.

ENDS

About TVM Capital Healthcare

Advertisement

TVM Capital Healthcare is a global healthcare private equity firm specializing in emerging markets. Based in Dubai and Singapore, with offices in Riyadh and Ho Chi Minh City, the firm invests expansion and growth capital in healthcare companies to improve local access to quality and affordable care, as well as local sources of medical products in the pharma, medical device, and diagnostics sectors. Investment and operating partners, as well as a strong group of regional and international senior advisors, have long-standing track records in healthcare investing and deep operating experience in the Middle East and Southeast Asia.

Medical quality is safeguarded by collaborations with leading international medical technology and clinical partners such as Mass General Hospital as well as international accreditation agencies such as Joint Commission International (JCI). TVM Capital Healthcare’s investment and operating approach combines strong commercial value creation and financial returns with responsible and sustainable investment in alignment with the United Nations Sustainable Development Goals. Our proven strategy in the critical sector of healthcare also includes climate adaptation and resilience.www.tvmcapitalhealthcare.com

Contact:

Holly Radel
[email protected] 

Logo – https://mma.prnewswire.com/media/1446186/2740341/TVM_Capital_Healthcare_Logo.jpg 

Cision View original content:https://www.prnewswire.co.uk/news-releases/tvm-capital-healthcare-announces-investment-in-human-longevity-inc-as-part-of-its-strategy-of-supporting-disease-prevention-and-healthy-aging-302247907.html

Continue Reading

Trending